Your browser doesn't support javascript.
loading
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.
Hernandez, Ainhoa; Muñoz-Mármol, Ana Maria; Esteve-Codina, Anna; Alameda, Francesc; Carrato, Cristina; Pineda, Estela; Arpí-Lluciá, Oriol; Martinez-García, Maria; Mallo, Mar; Gut, Marta; Del Barco, Sonia; Gallego, Oscar; Dabad, Marc; Mesia, Carlos; Bellosillo, Beatriz; Domenech, Marta; Vidal, Noemí; Aldecoa, Iban; de la Iglesia, Nuria; Balana, Carmen.
Afiliación
  • Hernandez A; Institut Catala d'Oncologia (ICO) Badalona, Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias I Pujol (IGTP), Carretera Canyet s/n, 08916, Badalona, Spain.
  • Muñoz-Mármol AM; Pathology Department, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
  • Esteve-Codina A; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Alameda F; Pathology Department, Neuropathology Unit, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Carrato C; Pathology Department, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
  • Pineda E; Medical Oncology, Hospital Clínic, Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Arpí-Lluciá O; Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Martinez-García M; Medical Oncology, Hospital del Mar, Barcelona, Spain.
  • Mallo M; Institut de Recerca Contra La Leucèmia Josep Carreras, Badalona, Spain.
  • Gut M; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Del Barco S; Medical Oncology, Institut Catala d'Oncologia (ICO) Girona, Hospital Josep Trueta, Girona, Spain.
  • Gallego O; Medical Oncology, Hospital de Sant Pau, Barcelona, Spain.
  • Dabad M; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Mesia C; Neuro-Oncology Unit and Medical Oncology Department, Institut Catala d'Oncologia (ICO) Bellvitge, Institut de Investigació Bellvitge (IDIBELL), L'Hospitalet, Barcelona, Spain.
  • Bellosillo B; Pathology Department, Neuropathology Unit, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Domenech M; Institut Catala d'Oncologia (ICO) Badalona, Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias I Pujol (IGTP), Carretera Canyet s/n, 08916, Badalona, Spain.
  • Vidal N; Pathology Department, Hospital Universitari de Bellvitge, Bellvitge, Spain.
  • Aldecoa I; Department of Pathology, Biomedical Diagnostic Centre (CDB) and Neurological Tissue Bank of the Biobank-IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • de la Iglesia N; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
  • Balana C; Institut Catala d'Oncologia (ICO) Badalona, Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias I Pujol (IGTP), Carretera Canyet s/n, 08916, Badalona, Spain. cbalana@iconcologia.net.
Sci Rep ; 12(1): 14439, 2022 08 24.
Article en En | MEDLINE | ID: mdl-36002559
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glioblastoma / Glioma Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glioblastoma / Glioma Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: España